Innovative Medical Management Co Ltd (002173) — Working Capital to Net Assets Ratio
Innovative Medical Management Co Ltd (002173) has a Working Capital to Net Assets ratio of 15.8% as of September 2025. Working capital of CN¥283.47 Million (current assets of CN¥571.28 Million minus current liabilities of CN¥287.80 Million) is measured against net assets of CN¥1.79 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See 002173 equity financing ratio to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Innovative Medical Management Co Ltd Working Capital to Net Assets (2004–2024)
This chart shows how Innovative Medical Management Co Ltd's Working Capital to Net Assets ratio has evolved across 21 annual periods from 2004 to 2024. As of September 2025, the ratio stands at 15.8%, reflecting working capital of CN¥283.47 Million against net assets of CN¥1.79 Billion CNY. Check Innovative Medical Management Co Ltd tangible equity quality to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for Innovative Medical Management Co Ltd (2004–2024)
The table below presents the year-by-year Working Capital to Net Assets ratio for Innovative Medical Management Co Ltd from 2004 to 2024, covering 21 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see market value of Innovative Medical Management Co Ltd.
| Year | WC/NA Ratio | Working Capital (CNY) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 15.6% | CN¥277.64 Million | CN¥1.78 Billion | CN¥598.85 Million | CN¥321.21 Million | ▼ -6.2 pp |
| 2023 | 21.8% | CN¥407.63 Million | CN¥1.87 Billion | CN¥733.06 Million | CN¥325.43 Million | ▼ -1.8 pp |
| 2022 | 23.6% | CN¥449.28 Million | CN¥1.91 Billion | CN¥771.65 Million | CN¥322.36 Million | ▼ -6.3 pp |
| 2021 | 29.8% | CN¥594.05 Million | CN¥1.99 Billion | CN¥940.02 Million | CN¥345.97 Million | ▼ -5.7 pp |
| 2020 | 35.5% | CN¥761.56 Million | CN¥2.14 Billion | CN¥1.12 Billion | CN¥358.39 Million | ▼ -1.4 pp |
| 2019 | 36.9% | CN¥911.87 Million | CN¥2.47 Billion | CN¥1.23 Billion | CN¥315.80 Million | ▲ +2.3 pp |
| 2018 | 34.6% | CN¥1.25 Billion | CN¥3.62 Billion | CN¥1.73 Billion | CN¥478.26 Million | ▼ -6.0 pp |
| 2017 | 40.6% | CN¥1.48 Billion | CN¥3.66 Billion | CN¥2.37 Billion | CN¥885.94 Million | ▼ -2.3 pp |
| 2016 | 42.9% | CN¥1.51 Billion | CN¥3.53 Billion | CN¥2.31 Billion | CN¥794.70 Million | ▼ -21.4 pp |
| 2015 | 64.3% | CN¥265.64 Million | CN¥413.37 Million | CN¥920.48 Million | CN¥654.84 Million | ▼ -3.0 pp |
| 2014 | 67.3% | CN¥322.00 Million | CN¥478.62 Million | CN¥879.39 Million | CN¥557.39 Million | ▼ -19.1 pp |
| 2013 | 86.4% | CN¥433.32 Million | CN¥501.53 Million | CN¥873.64 Million | CN¥440.32 Million | ▼ -0.4 pp |
| 2012 | 86.8% | CN¥451.73 Million | CN¥520.22 Million | CN¥835.02 Million | CN¥383.29 Million | ▲ +18.3 pp |
| 2011 | 68.6% | CN¥319.46 Million | CN¥466.02 Million | CN¥758.97 Million | CN¥439.51 Million | ▼ -3.8 pp |
| 2010 | 72.3% | CN¥314.09 Million | CN¥434.36 Million | CN¥707.96 Million | CN¥393.86 Million | ▼ -5.5 pp |
| 2009 | 77.8% | CN¥314.32 Million | CN¥403.89 Million | CN¥683.82 Million | CN¥369.50 Million | ▼ -1.3 pp |
| 2008 | 79.1% | CN¥309.67 Million | CN¥391.58 Million | CN¥575.06 Million | CN¥265.39 Million | ▼ -2.2 pp |
| 2007 | 81.3% | CN¥284.39 Million | CN¥349.87 Million | CN¥535.57 Million | CN¥251.18 Million | ▲ +17.8 pp |
| 2006 | 63.5% | CN¥85.25 Million | CN¥134.18 Million | CN¥316.65 Million | CN¥231.40 Million | ▲ +3.4 pp |
| 2005 | 60.1% | CN¥61.51 Million | CN¥102.34 Million | CN¥212.29 Million | CN¥150.78 Million | ▼ -6.8 pp |
| 2004 | 66.9% | CN¥54.94 Million | CN¥82.10 Million | CN¥117.11 Million | CN¥62.17 Million | — |